Sign In
Buy AUPH
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH), BioCryst (BCRX) and Flexion Therapeutics (FLXN)
05:04pm, Monday, 09'th Mar 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aurinia Pharmaceuticals (AUPH), BioCryst (BCRX) and Flexion Therapeutics
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aurinia Pharmaceuticals (
AUPH
–
Research Report
), BioCryst (
BCRX
–
Research Report
) and Flexion Therapeutics (
Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (EYPT) and Aurinia Pharmaceuticals (AUPH)
12:23pm, Friday, 06'th Mar 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on EyePoint Pharmaceuticals (EYPT) and Aurinia
Companies in the
Healthcare sector have received a lot of coverage today as analysts
weigh in on EyePoint Pharmaceuticals (
EYPT
–
Research Report
) and Aurinia Pharmaceuticals (
AUPH
–
Research R
Cantor Fitzgerald Maintains Overweight on Aurinia Pharmaceuticals, Raises Price Target to $32
12:00am, Friday, 06'th Mar 20207 Stocks Moving In Thursday's After-Hours Session
10:22pm, Thursday, 05'th Mar 2020
Gainers
Okta (NASDAQ: OKTA) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results. The company issued Q1 and FY21 sales guidance...
Aurinia Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 EPS results.
12:00am, Thursday, 05'th Mar 2020H.C. Wainwright Maintains Their Buy Rating on Arcturus Therapeutics (ARCT)
05:14pm, Wednesday, 04'th Mar 2020
In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Arcturus Therapeutics (ARCT), with a price target of $18.00. The
H.C. Wainwright Maintains Their Buy Rating on Arcturus Therapeutics (ARCT)
05:14pm, Wednesday, 04'th Mar 2020
In a report released today,
Ed Arce
from H.C. Wainwright maintained a
Buy
rating on Arcturus Therapeutics (
ARCT
–
Research Report
), with a price target of
$18.00
. The company’s shares closed la
Largest borrow rate increases among liquid names WPG;WLL;AUPH;NVTA;JNK;GTT;GME;DO;BKLN;PYX
01:45pm, Wednesday, 04'th Mar 2020
Largest borrow rate increases among liquid names WPG WLL AUPH NVTA JNK GTT GME DO BKLN PYX
Analysts Are Bullish on These Healthcare Stocks: Antares Pharma (ATRS), Durect (DRRX)
12:29pm, Wednesday, 04'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Antares Pharma (ATRS) and Durect (DRRX) with bullish
Analysts Are Bullish on These Healthcare Stocks: Antares Pharma (ATRS), Durect (DRRX)
12:29pm, Wednesday, 04'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Antares Pharma (
ATRS
–
Research Report
) and Durect (
DRRX
–
Research Report
) with bullish sentim
Do Options Traders Know Something About Aurinia (AUPH) Stock We Don't?
12:00am, Wednesday, 04'th Mar 2020H.C. Wainwright Maintains a Buy Rating on Albireo Pharma (ALBO)
12:15pm, Tuesday, 03'rd Mar 2020
H.C. Wainwright analyst Ed Arce maintained a Buy rating on Albireo Pharma (ALBO) today and set a price target of $62.00. The company's shares closed last
